Jesse Coleman to Present AIPLA Webinar
Trading Secrets
MAY 16, 2023
The roundtable of presenters will discuss recent development in trade secrets, and offer insight on how to effectively work with damage experts in trade secrets litigation.
Trading Secrets
MAY 16, 2023
The roundtable of presenters will discuss recent development in trade secrets, and offer insight on how to effectively work with damage experts in trade secrets litigation.
LexBlog IP
MAY 16, 2023
The roundtable of presenters will discuss recent development in trade secrets, and offer insight on how to effectively work with damage experts in trade secrets litigation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
MAY 18, 2023
Use of Damages Expert to Help Establish Causation The panelists also discussed the how the use of damages experts in trade secrets litigation may be instrumental in addressing causation and highlighting the link between trade secret misappropriation and the alleged economic harm suffered by the plaintiff.
Trading Secrets
MAY 18, 2023
Use of Damages Expert to Help Establish Causation The panelists also discussed the how the use of damages experts in trade secrets litigation may be instrumental in addressing causation and highlighting the link between trade secret misappropriation and the alleged economic harm suffered by the plaintiff.
43(B)log
SEPTEMBER 6, 2021
The district court excluded the plaintiff’s damages expert, finding that he didn’t apply a reliable methodology in assessing causation of damages because he discounted competing causal factors without an adequate basis and lacked the necessary expertise to make those judgments.
The IPKat
JANUARY 16, 2022
In January and February WIPO will host webinars on the following topics: " ISNI: Numbering public names for the creative industries ", " Rights Data and Identifiers for Musical Works and Rights Holders " and " Rights data and identifiers for performers ". What are the boundaries on copyright protection for video games?
Patently-O
NOVEMBER 29, 2023
Article III standing remains a hot topic at all levels of federal litigation and across many different areas of law. With surgery as the only viable course of treatment, Cloudbreak Therapeutics created a topical application of multikinase inhibitors to provide a non-surgical treatment to prevent recurring tumors, which is recognized in U.S.
Let's personalize your content